ABT - Abbott Laboratories
(NaN%)
SNP 500
Buy
Strong Growth and Improving●Stock Price High
68%
based on last 5 year data.
Income Statement is STRONG
Revenue Growth is 5.85%
Operating Income Growth is 15.94%
Net Income Growth is 152.49%
Earnings Per Share (EPS) Growth is 151.42%
Net Margin is 32.33%
Balance Sheet is STRONG
Current Asset to Current Liability Ratio is 1.82
Debt Ratio is 0.16
Current Debt to Net Income Ratio is 0.28
Total Debt to Total Assets Ratio is 0.16
Cash Flow is STRONG
Cash from Operations Growth is 14.39%
Capital Expenditure is Low
Net Increase in Cash is Negative
Long Term Score Trend is POSITIVE
Investment Risk is Moderate
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Abbott Laboratories (ABT) - https://www.abbott.com/
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.Exchange - NEW YORK STOCK EXCHANGE INC.
Industry - Surgical and Medical Instrument Manufacturing
Sector - Manufacturing
CEO -
Employees - 115,000
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2025 and future.
Know the Stock © 2025 and future.